Cite
HARVARD Citation
Ross, S. et al. (n.d.). Efficacy and safety of empagliflozin twice daily versus once daily in patients with type 2 diabetes inadequately controlled on metformin: a 16‐week, randomized, placebo‐controlled trial. Diabetes, obesity & metabolism. 17 (7), pp. 699-702. [Online].